TapewireFind a company

person · Reporting owner

Hammer Amanda Elizabeth

Disclosed activity across 1 company

Tapewire entity
90233
SEC CIK
0001974354

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MANGOCEUTICALS, INC.MGRX · Entity 8073Chief Operating OfficerJune 03, 2024June 05, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MANGOCEUTICALS, INC.

Report date June 03, 2024 · Filed June 05, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect175,000 Reported balance After 2024-06-03 transaction · row 1
1 source row

Row 1 · 2024-06-03 · Grant · Acquired 100,000 · Balance 175,000

F1: Issued in consideration for services rendered as Chief Operating Officer. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

Filing footnotes · ownership attribution and instrument terms

F1: Issued in consideration for services rendered as Chief Operating Officer. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 03, 2024 Filed Jun 5, 2024 21:15 UTC MANGOCEUTICALS, INC. MGRX · Entity 8073 GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-022806 · ownership.xml · nonDerivative · entry 1

Hammer Amanda Elizabeth · CIK 0001974354 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

F1 · kind: Issued in consideration for services rendered as Chief Operating Officer. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

F1 · price: Issued in consideration for services rendered as Chief Operating Officer. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

Read SEC document
May 01, 2023 Filed May 4, 2023 14:42 UTC MANGOCEUTICALS, INC. MGRX · Entity 8073 GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.10 $0.00
Disclosure

SEC source: 0001493152-23-015393 · ownership.xml · derivative · entry 2

Hammer Amanda Elizabeth · CIK 0001974354 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-05-01

F2 · kind: The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan in consideration for services to be rendered as Chief Operating Officer. Granted under the registrant's 2022 Equity Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.

F3 · derivative.exercise_date: The options vest at the rate of 1/3rd of such options on each of May 1, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Company on such vesting dates.

Read SEC document
May 01, 2023 Filed May 4, 2023 14:42 UTC MANGOCEUTICALS, INC. MGRX · Entity 8073 GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-015393 · ownership.xml · nonDerivative · entry 1

Hammer Amanda Elizabeth · CIK 0001974354 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · kind: Issued as a sign-on bonus for agreeing to become the Chief Operating Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

F1 · price: Issued as a sign-on bonus for agreeing to become the Chief Operating Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.